{
  "disease_name": "Primary hyperoxaluria",
  "orpha_code": "416",
  "trials": [
    {
      "nctId": "NCT04580420",
      "briefTitle": "Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD",
      "officialTitle": "A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis",
      "overallStatus": "RECRUITING",
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Primary Hyperoxaluria Type 1",
        "End Stage Renal Disease"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "DCR-PHXC"
        }
      ],
      "enrollment": 28,
      "locations": [
        {
          "facility": "Clinical Trial Site",
          "city": "San Francisco",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Boston",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Rochester",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "New York",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bron",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Paris",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bonn",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Heidelberg",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Roma",
          "country": "Italy"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Beirut",
          "country": "Lebanon"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Casablanca",
          "country": "Morocco"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Oradea",
          "country": "Romania"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Oradea",
          "country": "Romania"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Barcelona",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Santa Cruz De Tenerife",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Dubai",
          "country": "United Arab Emirates"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "London",
          "country": "United Kingdom"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "London",
          "country": "United Kingdom"
        }
      ],
      "lastUpdateDate": "2025-05-15"
    },
    {
      "nctId": "NCT04042402",
      "briefTitle": "Long Term Extension Study in Patients With Primary Hyperoxaluria",
      "officialTitle": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
      "overallStatus": "ACTIVE_NOT_RECRUITING",
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Primary Hyperoxaluria Type 1 (PH1)",
        "Primary Hyperoxaluria Type 2 (PH2)",
        "Kidney Diseases",
        "Urologic Diseases",
        "Genetic Disease",
        "Primary Hyperoxaluria Type 3 (PH3)"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "DCR-PHXC"
        }
      ],
      "enrollment": 75,
      "locations": [
        {
          "facility": "Clinical Research Site",
          "city": "San Francisco",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Boston",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Rochester",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "New York",
          "country": "United States"
        },
        {
          "facility": "Clinical Research Site",
          "city": "Herston",
          "country": "Australia"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Melbourne",
          "country": "Australia"
        },
        {
          "facility": "Clinical Research Site",
          "city": "Hamilton",
          "country": "Canada"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bron",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Paris",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bonn",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Heidelberg",
          "country": "Germany"
        },
        {
          "facility": "Clinical Research Site",
          "city": "Roma",
          "country": "Italy"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Fukuoka",
          "country": "Japan"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Nagoya",
          "country": "Japan"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Tokyo",
          "country": "Japan"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Beirut",
          "country": "Lebanon"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Amsterdam",
          "country": "Netherlands"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Tromsø",
          "country": "Norway"
        },
        {
          "facility": "Clinical Research Site",
          "city": "Barcelona",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Barcelona",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Ankara",
          "country": "Turkey"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Hampstead",
          "country": "United Kingdom"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Birmingham",
          "country": "United Kingdom"
        }
      ],
      "lastUpdateDate": "2025-05-30"
    },
    {
      "nctId": "NCT04982393",
      "briefTitle": "BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)",
      "officialTitle": "BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)",
      "overallStatus": "RECRUITING",
      "studyType": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Primary Hyperoxaluria Type 1"
      ],
      "interventions": [],
      "enrollment": 200,
      "locations": [
        {
          "facility": "Clinical Trial Site",
          "city": "Phoenix",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Washington",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Boston",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Rochester",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Cincinnati",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Pittsburgh",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Dallas",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Houston",
          "country": "United States"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Gent",
          "country": "Belgium"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Liège",
          "country": "Belgium"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Hamilton",
          "country": "Canada"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Toronto",
          "country": "Canada"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Laurier",
          "country": "Canada"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bordeaux",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Lyon",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Paris",
          "country": "France"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Berlin",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Cologne",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Hamburg",
          "country": "Germany"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Jerusalem",
          "country": "Israel"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Orbassano",
          "country": "Italy"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Milan",
          "country": "Italy"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Verona",
          "country": "Italy"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Amsterdam",
          "country": "Netherlands"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Santa Cruz de Tenerife",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Barcelona",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Las Palmas",
          "country": "Spain"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "Bern",
          "country": "Switzerland"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "London",
          "country": "United Kingdom"
        },
        {
          "facility": "Clinical Trial Site",
          "city": "London",
          "country": "United Kingdom"
        }
      ],
      "lastUpdateDate": "2025-05-13"
    }
  ],
  "processing_timestamp": "2025-07-07T03:14:00.404504",
  "run_number": 1,
  "total_trials_found": 3
}